The rationality of the targeted antiproliferative activity of MGL elaborates from the tumor cell's lack of activated methionine synthase, as an exceptional metabolic standard, justifying their dependence on the extrinsic plasma L-methionine (Sun et al., 2003). The gene discussed is MTR; the disease is neoplasm.